El-Ashry D - Search Results

1

Breast cancer, stem/progenitor cells and the estrogen receptor.

Dontu G, El-Ashry D, Wicha MS. Dontu G, et al. Trends Endocrinol Metab. 2004 Jul;15(5):193-7. doi: 10.1016/j.tem.2004.05.011. Trends Endocrinol Metab. 2004. PMID: 15223047 Review.

2

Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells.

Yarden RI, Lauber AH, El-Ashry D, Chrysogelos SA. Yarden RI, et al. Endocrinology. 1996 Jul;137(7):2739-47. doi: 10.1210/endo.137.7.8770893. Endocrinology. 1996. PMID: 8770893

3

Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.

Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. Oh AS, et al. Mol Endocrinol. 2001 Aug;15(8):1344-59. doi: 10.1210/mend.15.8.0678. Mol Endocrinol. 2001. PMID: 11463858

4

Estrogen receptor expression and sensitivity to paclitaxel in breast cancer.

Dougherty MK, Schumaker LM, Jordan VC, Welshons WV, Curran EM, Ellis MJ, El-Ashry D. Dougherty MK, et al. Cancer Biol Ther. 2004 May;3(5):460-7. doi: 10.4161/cbt.3.5.810. Epub 2004 May 18. Cancer Biol Ther. 2004. PMID: 15020841 Free article.

5

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.

Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Creighton CJ, et al. Cancer Res. 2006 Apr 1;66(7):3903-11. doi: 10.1158/0008-5472.CAN-05-4363. Cancer Res. 2006. PMID: 16585219

6

Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.

Bayliss J, Hilger A, Vishnu P, Diehl K, El-Ashry D. Bayliss J, et al. Clin Cancer Res. 2007 Dec 1;13(23):7029-36. doi: 10.1158/1078-0432.CCR-07-0587. Clin Cancer Res. 2007. PMID: 18056179

7

Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype.

Shah SH, Miller P, Garcia-Contreras M, Ao Z, Machlin L, Issa E, El-Ashry D. Shah SH, et al. Cancer Biol Ther. 2015;16(11):1671-81. doi: 10.1080/15384047.2015.1071742. Epub 2015 Jul 17. Cancer Biol Ther. 2015. PMID: 26186233 Free PMC article.

8

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

Miller P, Kidwell KM, Thomas D, Sabel M, Rae JM, Hayes DF, Hudson BI, El-Ashry D, Lippman ME. Miller P, et al. Breast Cancer Res Treat. 2017 Nov;166(1):85-94. doi: 10.1007/s10549-017-4366-6. Epub 2017 Jul 17. Breast Cancer Res Treat. 2017. PMID: 28717852

9

Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.

Diep CH, Spartz A, Truong TH, Dwyer AR, El-Ashry D, Lange CA. Diep CH, et al. Among authors: el ashry d. Endocrinology. 2024 Jul 26;165(9):bqae092. doi: 10.1210/endocr/bqae092. Endocrinology. 2024. PMID: 39041201

10

MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Liu Y, el-Ashry D, Chen D, Ding IY, Kern FG. Liu Y, et al. Breast Cancer Res Treat. 1995 May;34(2):97-117. doi: 10.1007/BF00665783. Breast Cancer Res Treat. 1995. PMID: 7647336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters